On this page
Thomas C Lyman
Insider
First SEC filing: July 27, 2007 · Latest: July 27, 2007
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 27, 2007 | CZFS | P | 1 | $21.85 | $22 | 153 Indirect | +0.66% | Acquired | 321.0% (price as of 2026-10-02) |
| July 27, 2007 | CZFS | P | 5 | $21.85 | $109 | 578 Direct | +0.87% | Acquired | 321.0% (price as of 2026-10-02) |
| May 11, 2007 | CZFS | A | 293 | · | · | 571 Direct | +105.40% | Acquired | (price as of 2026-10-02) |
| May 11, 2007 | CZFS | A | 293 | $22.75 | $6,666 | 571 Direct | +105.40% | Acquired | 308.4% (price as of 2026-10-02) |
| July 28, 2006 | CZFS | P | 1 | $21.78 | $22 | 153 Indirect | +0.66% | Acquired | 326.6% (price as of 2026-10-02) |
| July 28, 2006 | CZFS | P | 3 | $21.78 | $65 | 270 Direct | +1.12% | Acquired | 326.6% (price as of 2026-10-02) |
| July 29, 2005 | CZFS | P | 1 | $21.00 | $21 | 152 Indirect | +0.66% | Acquired | 346.8% (price as of 2026-10-02) |
| July 29, 2005 | CZFS | P | 3 | $21.00 | $63 | 258 Direct | +1.18% | Acquired | 346.8% (price as of 2026-10-02) |
| July 30, 2004 | CZFS | P | 1 | $22.35 | $22 | 151 Indirect | +0.67% | Acquired | 324.0% (price as of 2026-10-02) |
| July 30, 2004 | CZFS | P | 2 | $22.35 | $45 | 247 Direct | +0.82% | Acquired | 324.0% (price as of 2026-10-02) |
| June 14, 2004 | CZFS | P | 150 | $22.75 | $3,412 | 150 Indirect | · | Acquired | 316.6% (price as of 2026-10-02) |
| Dec. 15, 2003 | CZFS | P | 8 | $23.84 | $191 | 241 Direct | +3.43% | Acquired | 297.5% (price as of 2026-10-02) |
| July 25, 2003 | CZFS | P | 2 | $27.62 | $55 | 229 Direct | +0.88% | Acquired | 243.1% (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.